Loading...
Dr.reddy's Laboratories Ltd — Doxorubicin Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #2 for Doxorubicin · $2.5M export value · DGFT Verified
Dr.reddy's Laboratories Ltd is the #2 Indian exporter of Doxorubicin with $2.5M in export value and 51 verified shipments. Dr.reddy's Laboratories Ltd holds a 3.8% market share in Doxorubicin exports across 11 countries.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.7M | 35 | 64.0% |
| SAUDI ARABIA | $588.4K | 12 | 21.7% |
| MEXICO | $100.0K | 2 | 3.7% |
| SOUTH AFRICA | $83.2K | 2 | 3.1% |
| BANGLADESH | $66.8K | 3 | 2.5% |
| UKRAINE | $50.0K | 1 | 1.8% |
| TAIWAN | $50.0K | 1 | 1.8% |
| CHILE | $28.5K | 1 | 1.0% |
| MALDIVES | $5.6K | 1 | 0.2% |
| UZBEKISTAN | $3.7K | 2 | 0.1% |
Dr.reddy's Laboratories Ltd exports Doxorubicin to 11 countries. The largest destination is UNITED STATES accounting for 64.0% of Dr.reddy's Laboratories Ltd's Doxorubicin shipments, followed by SAUDI ARABIA (21.7%) and MEXICO (3.7%). These destinations reflect Dr.reddy's Laboratories Ltd's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| DR REDDYS LABORATORIES,INC | UNITED STATES | $1.1M | 22 |
| SUDAIR PHARMA UNIT 6 | SAUDI ARABIA | $188.4K | 4 |
| AMERISOURCE HEALTH SERVICES | UNITED STATES | $150.0K | 3 |
| SUDAIR PHARMA UNIT 6 P.O.BOX 19047 | SAUDI ARABIA | $150.0K | 3 |
| SAB P.O BOX67 JEDDAH 21411 | SAUDI ARABIA | $150.0K | 3 |
| DR REDDYS LABORATORIES INC |
India exported $21.8M worth of Doxorubicin through 3,492 shipments from 310 suppliers to 136 countries, serving 899 buyers globally. Dr.reddy's Laboratories Ltd contributes $2.5M to this total, accounting for 3.8% of India's Doxorubicin exports. Dr.reddy's Laboratories Ltd ships Doxorubicin to 11 countries through 23 buyers.
Dr.reddy's Laboratories Ltd's average Doxorubicin shipment value is $50.0K per consignment, based on 51 shipments totaling $2.5M. The largest destination is UNITED STATES (64.0% of Dr.reddy's Laboratories Ltd's Doxorubicin exports).
Dr.reddy's Laboratories Ltd ranks #2 among 310 Indian Doxorubicin exporters with a 3.8% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($7.5M), FRESENIUS KABI ONCOLOGY LIMITED ($3.1M), DR.REDDY'S LABORATORIES LTD ($2.5M). Dr.reddy's Laboratories Ltd processed 51 shipments to 11 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| 300026772 DOXORUBICIN HYDROCHLORIDE LIPO | $425.2K | 9 |
| DOXORUBICIN HYDROCHLORIDE LIPOSOME INJEC | $399.0K | 13 |
| 300026282 DOXORUBICIN HYDROCHLORIDE LIPO | $300.0K | 6 |
| DOXORUBICIN HCL LIPOSOME INJ 50MG/25ML | $150.0K | 3 |
| DOXORUBICIN HCL LIPOSOME INJ 20MG/10ML | $150.0K | 3 |
| DOXORUBICIN HCL LIPOSOME INJ. (20MG/10ML) | $150.0K | 3 |
| 300028613 DOXORUBICIN HYDROCHLORIDE LIPO | $100.0K | 2 |
| 300028614 DOXORUBICIN HYDROCHLORIDE LIPO | $100.0K | 2 |
| DOXORUBICINA 10ML 2MG/ML INJ 1'S |
What Dr.reddy's Laboratories Ltd must comply with to export Doxorubicin to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Approval Process
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $7.5M | 149 | 15 | $50.0K |
| 3 | FRESENIUS KABI ONCOLOGY LIMITED | $3.1M | 143 | 18 | $21.5K |
| 2 | DR.REDDY'S LABORATORIES LTD ★ | $2.5M | 51 | 11 | $50.0K |
| 6 | INTAS PHARMACEUTICALS LIMITED | $1.8M |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 639 | 18.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 577 | 16.5% |
| DELHI AIR CARGO ACC (INDEL4) | 464 | 13.3% |
| DELHI AIR | 399 | 11.4% |
| Bombay Air | 188 | 5.4% |
| AHEMDABAD AIR | 150 | 4.3% |
| AHEMDABAD AIR ACC (INAMD4) | 120 | 3.4% |
| Delhi Air | 85 | 2.4% |
Latest developments and market context
Detailed market intelligence for Doxorubicin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Dr.reddy's Laboratories Ltd's Doxorubicin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
| UNITED STATES |
| $100.0K |
| 2 |
| NORTHSTAR RX LLC | UNITED STATES | $100.0K | 2 |
| ABASTECEDORA DE INSUMOS | MEXICO | $100.0K | 2 |
| AMERISOURCE HEALTH SERVICES DBA | UNITED STATES | $100.0K | 2 |
| NORTHSTAR RX LLC, | UNITED STATES | $100.0K | 2 |
Dr.reddy's Laboratories Ltd supplies Doxorubicin to 23 buyers globally. The largest buyer is DR REDDYS LABORATORIES,INC (UNITED STATES), followed by SUDAIR PHARMA UNIT 6 (SAUDI ARABIA) and AMERISOURCE HEALTH SERVICES (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| $100.0K |
| 2 |
| 300028985 DOXORUBICIN HYDROCHLORIDE LIPO | $50.0K | 1 |
Dr.reddy's Laboratories Ltd exports 27 distinct Doxorubicin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is 300026772 DOXORUBICIN HYDROCHLORIDE LIPO with 9 shipments worth $425.2K.
Generic registration under Mexican health law. NOM standards apply.
Timeline: 12–18 months
GMP & Export Requirements
Mexican GMP (NOM-059-SSA1); COFEPRIS overseas inspection or PIC/S certificate
Sanitary Import Permit from COFEPRIS; import licence via SAT
Note: COFEPRIS participates in PIC/S, easing recognition of PIC/S certificates from Indian authorities.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
| 393 |
| 16 |
| $4.6K |
| 7 | EUGIA PHARMA SPECIALITIES LIMITED | $1.4M | 98 | 1 | $14.7K |
Dr.reddy's Laboratories Ltd ranks #2 among 310 Indian Doxorubicin exporters. Average shipment value of $50.0K compared to the market average of $70.4K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and FRESENIUS KABI ONCOLOGY LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 136+ countries, 899+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Dr.reddy's Laboratories Ltd.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Doxorubicin. For current shipment-level data, contact TransData Nexus.